Kenota Health raises 11 million in funding to bring point of care allergy testing to healthcare clinics
Ce communiqué n'est disponible que dans la langue dans laquelle il a été rédigé.
WATERLOO, ON, Dec. 7, 2020 /PRNewswire/ – Kenota Health Inc., an innovative medical technology company based in Canada, has raised $11 million in funding with the aim of providing rapid and reliable allergy testing for physicians to test and treat more patients within a single clinic visit.